Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth Read more about Fennec Pharmaceuticals Strengthens Executive Leadership Team with Three Key Appointments to Accelerate the Company’s Next Stage of Growth
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences Read more about Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024 Read more about Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director Read more about Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director
Fennec Pharmaceuticals Announces Management Change Read more about Fennec Pharmaceuticals Announces Management Change
Fennec Announces Results of Annual Meeting Read more about Fennec Announces Results of Annual Meeting
Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024 Read more about Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update Read more about Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
